Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice

Biochemical and Biophysical Research Communications

Volumn 317, Issue 4, 2004, Pages 992-999

  Hattori, Yoshiyuki ^a   Kawakami, Shigeru ^a   Suzuki, Sachiko ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cationic liposome; DNA vaccine; Gene delivery; Mannosylated liposome; Plasmid DNA; Targeting

Indexed keywords

CATION; CHOLESTEROL; DNA VACCINE; DRUG CARRIER; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 12; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG SCREENING; FEMALE; GENE CONSTRUCT; GENE TARGETING; GENETIC CODE; IMMUNE RESPONSE; INFLAMMATION; INTERMETHOD COMPARISON; MACROPHAGE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; TH1 CELL; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11C; CHICKENS; CYTOKINES; CYTOMEGALOVIRUS; DENDRITIC CELLS; FEMALE; GENE TRANSFER TECHNIQUES; INTERFERON TYPE II; LIPOSOMES; MACROPHAGES, PERITONEAL; MANNOSE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; OVALBUMIN; PARTICLE SIZE; SPLEEN; T-LYMPHOCYTES; VACCINES, DNA;

EID: 1942451887     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.141     Document Type: Article

References (38)

1. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
2. Schirmbeck R., Bohm W., Ando K., Chisari F.V., Reimann J. Nucleic acid vaccination primes hepatitis B surface antigen specific cytotoxic T lymphocytes in non-responder mice. J. Virol. 69:1995;5929-5934.
3. + cell-, interferon γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1996;1739-1946.
4. Nishimura T., Nakui M., Sato M., Iwakabe K., Kitamura H., Sekimoto M., Ohta A., Koda T., Nishimura S. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother. Pharmacol. 46:2000;S52-S61.
5. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189:1999;169-178.
6. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
7. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
8. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
9. + T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine. 19:2000;764-778.
10. Rosenberg S.A., Yang J.C., Sherry R.M., Hwu P., Topalian S.L., Schwartzentruber D.J., Restifo N.P., Haworth L.R., Seipp C.A., Freezer L.J., Morton K.E., Mavroukakis S.A., White D.E. Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen. Hum. Gene Ther. 14:2003;709-714.
11. Huang L., Li S. Liposomal gene delivery: a complex package. Nat. Biotechnol. 15:1997;620-621.
12. Hashida M., Nishikawa M., Yamashita F., Takakura Y. Cell-specific delivery of genes with glycosylated carriers. Adv. Drug Deliv. Rev. 52:2001;187-196.
13. Kawakami S., Yamashita F., Nishida K., Nakamura J., Hashida M. Glycosylated cationic liposomes for cell-selective gene delivery. Crit. Rev. Ther. Drug Carrier Syst. 19:2002;171-190.
14. Gregoriadis G., Saffie R., de Souza B. Liposome-mediated DNA vaccination. FEBS Lett. 402:1997;107-110.
15. Klavinskis L.S., Gao L., Barnfield C., Lehner T., Parker S. Mucosal immunization with DNA-liposome complexes. Vaccine. 15:1997;818-820.
16. Perrie Y., Frederik P.M., Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine. 19:2001;3301-3310.
17. Ishii N., Fukushima J., Kaneko T., Okada E., Tani K., Tanaka S.I., Hamajima K., Xin K.Q., Kawamoto S., Koff W., Nishioka K., Yasuda T., Okuda K. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 13:1997;1421-1428.
18. Tanaka M., Kaneda Y., Fujii S., Yamano T., Hashimoto K., Huang S.K., Hoon D.S. Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma. Mol. Ther. 5:2002;291-299.
19. Toda S., Ishii N., Okada E., Kusakabe K.I., Arai H., Hamajima K., Gorai I., Nishioka K., Okuda K. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-γ antibody. Immunology. 92:1997;111-117.
20. Kawakami S., Sato A., Nishikawa M., Yamashita F., Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 7:2000;292-299.
21. Kawakami S., Wong J., Sato A., Hattori Y., Yamashita F., Hashida M. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim. Biophys. Acta. 1524:2000;258-265.
22. Farhood H., Serbina N., Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta. 1235:1995;289-295.
23. Kawakami S., Sato A., Yamada M., Yamashita F., Hashida M. The effect of lipid composition on receptor-mediated in vivo gene transfection using mannosylated cationic liposomes in mice. STP Pharma Sci. 11:2001;117-120.
24. Gao X., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:1991;280-285.
25. Potter N.S., Harding C.V. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J. Immunol. 167:2001;2538-2546.
26. Kawakami S., Yamashita F., Nishikawa M., Takakura Y., Hashida M. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem. Biophys. Res. Commun. 252:1998;78-83.
27. Lee Y.C., Stowell C.P., Krantz M.J. 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins. Biochemistry. 15:1976;3956-3963.
28. Kawakami S., Fumoto S., Nishikawa M., Yamashita F., Hashida M. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res. 17:2000;306-313.
29. Takagi T., Hashiguchi M., Mahato R.I., Tokuda H., Takakura Y., Hashida M. Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 245:1998;729-733.
30. Schattenberg D., Schott M., Reindl G., Krueger T., Tschoepe D., Feldkamp J., Scherbaum W.A., Seissler J. Response of human monocyte-derived dendritic cells to immunostimulatory DNA. Eur. J. Immunol. 30:2000;2824-2831.
31. Sakurai F., Terada T., Yasuda K., Yamashita F., Takakura Y., Hashida M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther. 9:2002;1120-1126.
32. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heeg K., Wagner H. Bacterial DNA causes septic shock. Nature. 386:1997;336-337.
33. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:1998;2045-2054.
34. Gately M.K., Gubler U., Brunda M.J., Nadeau R.R., Anderson T.D., Lipman J.M., Sarmiento U. Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases. Ther. Immunol. 1:1994;187-196.
35. M. Yamada, M. Nishikawa, S. Kawakami, Y. Hattori, T. Nakano, F. Yamashita, M. Hashida, Tissue and intrahepatic distribution and subcellular localization of a mannosylated cationic liposome/plasmid DNA complex after intravenous administration in mice, J. Control Release (in press)
36. Li S., Rizzo M.A., Bhattacharya S., Huang L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 5:1998;930-937.
37. Song Y.K., Liu F., Chu S., Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. 8:1997;1585-1594.
38. Zinkernagel R.M., Ehl S., Aichele P., Oehen S., Kundig T., Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:1997;199-209.